Food and Drug Administration (FILE PHOTO)

The Food and Drug Administration (FDA) has issued emergency use licenses to six brands of the anti-Covid-19 drug molnupiravir.

FDA officer in charge Oscar Gutierrez said the following had each been granted emergency use authorization (EUA):

  • Molnarz (Faberco)
  • Molnaflu (Medethix)
  • Auxilto (German Quality Pharma)
  • Molxvir (Sun Pharma)
  • Molnatris (Mykan)
  • Molnupiravir Generic (Lloyd Laboratories/Dr. Zen’s Research)

“Malinaw po sa findings ng FDA may capacity po siya mag-produce ng Molnupiravir capsules under current good manufacturing practice. At ang Molnupiravir naman ay meets the safety, efficacy, and quality standard as an investigatory Covid-19 drug,” Gutierrez said during President Rodrigo Duterte’s “Talk to the People” address aired on Monday night.

Gutierrez also disclosed that Pfizer had applied for an EUA for its anti-viral therapy pill, Paxlovid.

“Under evaluation na rin po ito. So puwede ako magbigay ng update uli sa darating na mga araw,” he said. John Ezekiel J. Hirro